Herpes Zoster in the Immunocompetent Patient: Management of Post-herpetic Neuralgia

Herpes

Volumn 10, Issue 2, 2003, Pages 38-45

  Johnson, Robert W ^a,b  

^a UNIVERSITY OF BRISTOL   (United Kingdom)

^b BRISTOL ROYAL INFIRMARY   (United Kingdom)

Author keywords

Acute herpes zoster; Elderly; Post herpetic neuralgia (PHN); Reactivation; Shingles; Varicella zoster virus (VZV); Zoster sine herpete; Zoster associated pain (ZAP)

Indexed keywords

ACICLOVIR; AMITRIPTYLINE; ANTICONVULSIVE AGENT; ANTIVIRUS AGENT; CARBAMAZEPINE; CHICKENPOX VACCINE; CODEINE; DESIPRAMINE; DIHYDROCODEINE; FAMCICLOVIR; GABAPENTIN; LAMOTRIGINE; LIDOCAINE; LIVE VACCINE; LOCAL ANESTHETIC AGENT; MAPROTILINE; METHADONE; METHYLPREDNISOLONE; MORPHINE; NORTRIPTYLINE; OPIATE; PHENYTOIN; PREGABALIN; PRODRUG; STEROID; TRAMADOL; TRICYCLIC ANTIDEPRESSANT AGENT; UNINDEXED DRUG; VALACICLOVIR; VALPROIC ACID;

AGGRESSION; ANTICHOLINERGIC EFFECT; ARACHNOIDITIS; ATAXIA; CLINICAL FEATURE; CLINICAL PROTOCOL; CLINICAL TRIAL; CONSTIPATION; DELIRIUM; DISEASE SEVERITY; DROWSINESS; DRUG DOSE REGIMEN; DRUG EFFECT; DRUG EFFICACY; DRUG SAFETY; DRUG TOLERABILITY; DRUG UTILIZATION; EARLY DIAGNOSIS; GLAUCOMA; HEALTH CARE COST; HEALTH CARE PERSONNEL; HEALTH EDUCATION; HERPES ZOSTER; HIGH RISK PATIENT; HUMAN; IMMUNOCOMPETENCE; INCREASED APPETITE; MEDICAL INFORMATION; MOOD DISORDER; NERVE BLOCK; OUTCOMES RESEARCH; PAIN; PAIN ASSESSMENT; PATIENT CARE; PATIENT COMPLIANCE; PATIENT EDUCATION; PERIPHERAL EDEMA; POSTHERPETIC NEURALGIA; PRACTICE GUIDELINE; PRIORITY JOURNAL; RASH; REVIEW; RISK ASSESSMENT; SCORING SYSTEM; SEDATION; SIDE EFFECT; SOCIAL SUPPORT; SOMNOLENCE; SYMPATHECTOMY; SYMPTOM; URINE RETENTION; VACCINATION; VERTIGO; VIRUS REACTIVATION; VISUAL IMPAIRMENT; XEROSTOMIA;

ANALGESICS; ANTIDEPRESSIVE AGENTS, TRICYCLIC; ANTIVIRAL AGENTS; DECISION TREES; HERPES ZOSTER; HUMANS; IMMUNOCOMPETENCE; NEURALGIA;

HUMAN HERPESVIRUS 3;

EID: 0345724844     PISSN: 09697667     EISSN: None     Source Type: Journal    
DOI: None     Document Type: Review

References (70)

1. Johnson RW, Dworkin RH. Treatment of herpes zoster and postherpetic neuralgia. BMJ 2003;326:748-750.
2. Smith PR, Hawrami K, Argent S, Mistry H, Johnson R, Breuer J. Clinical and laboratory diagnosis of shingles in East London. In: 6th Conference of the Federation of Infection Societies, December 1999, Manchester, UK.
3. Gilden DH, Wright RR, Schneck SA, Gwatlney JM, Jr, Mahalingham R. Zoster sine herpete, a clinical variant. Ann Neural 1994;35:530-533.
4. Hope-Simpson RE. The nature of herpes zoster: A long-term study and a new hypothesis. Proc Roy Soc Med 1965;58:2-20.
5. Raggozino MW, Melton LJ, Kurland LT. Population-based study of herpes zoster and its sequelae. Medicine 1982;61:310-316.
6. Edmunds WJ, Brisson M. The effect of vaccination on the epidemiology of varicella zoster virus. J Infect 2002;44:211-219.
7. Weksler ME. Immune senescence. Ann Neural 1994;35(Suppl):S35-S37.
8. Oxman MN. Immunization to reduce the frequency and severity of herpes zoster and its complications. Neurology 1995;45(Suppl 8):S41-S45.
9. Johnson MJ, Johnson RW. First steps towards the Zoster International Data Standard (ZIDS). Eur J Pain 1997;1:237-239.
10. Dworkin RH, Portenoy RK. Proposed classification of herpes zoster pain. Lancet 1994;343:1648.
11. Arani RB, Soong SJ, Weiss HL, Wood MJ, Fiddian PA, Gnann JW et al. Phase specific analysis of herpes zoster associated pain data: a new statistical approach. Stat Med 2001;20:2429-2439.
12. Wutzler P, Doerr HW, von Essen J. Epidemiology of herpes zoster. Biotest Bulletin 1997;5:301-306.
13. Bowsher D. The lifetime occurrence of herpes zoster and prevalence of postherpetic neuralgia: a retrospective survey in an elderly population. Eur J Pain 1999;3:335-342.
14. Wood MJ, Kay R, Dworkin RH, Soong SJ, Whitley RJ. Oral acyclovir therapy accelerates pain resolution in patients with herpes zoster: a meta-analysis of placebo-controlled trials. Clin Infect Dis 1996;22:341-347.
15. Helgason S, Petursson G, Gudmundsson S, Sigurdsson JA. Prevalence of postherpetic neuralgia after a first episode of herpes zoster: prospective study with long-term follow up. BMJ 2000;321:794-796.
16. Attal N, Bouhassira D. Mechanisms of pain in peripheral neuropathy, Acta Neurol Scand 1999;173:12-24.
17. Nurmikko TJ. Postherpetic neuralgia - a model for neuropathic pain? In: Neuropathic Pain: Pathology and Treatment (Marchettini P, ed). Seattle: IASP Press 2001; pp151-167.
18. Haanpaa M, Hakkinen V, Nurmikko T. Motor involvement in acute herpes zoster. Muscle Nerve 1997;20:1433-1438.
19. Nagasako EM, Johnson RW, Griffin DR, Dworkin RH. Rash severity in herpes zoster: correlates and relationship to postherpetic neuralgia. J Am Acad Dermatol 2002;46:834-839.
20. Dworkin RH, Nagasako EM, Johnson RW, Griffin DR. Acute pain in herpes zoster: the famciclovir database project. Pain 2001;94:113-119.
21. Whitley RJ, Weiss HL, Soong SJ, Gnann JW. Herpes zoster: risk categories for persistent pain. J Infect Dis 1999;179:9-15.
22. Bowsher D. Sensory change in postherpetic neuralgia. In: Herpes Zoster and Postherpetic Neuralgia (CPN Watson, ed). Amsterdam: Elsevier 1993:pp97-107.
23. Portenoy RK, Duma C, Foley KM. Acute herpetic and postherpetic neuralgia: clinical review and current management. Ann Neural 1986;20:651-664.
24. Rowbotham MC, Fields HL. Post-herpetic neuralgia: the relation of pain complaint, sensory disturbance, and skin temperature. Pain 1989;39:129-144.
25. Lydick E, Epstein RS, Himmelberger D, White CJ. Herpes zoster and quality of life: A self-limited disease with severe impact. Neurology 1995;45(Suppl 8): S52-S53.
26. Stewart AL, Hays RD, Ware JE, Jr. The MOS short-form general health survey: reliability and validity in a patient population. Med Care 1988;26:724-735.
27. Tyring S, Barbarash RA, Nahlik JE, Cunningham JE, Marley J, Heng M et al. Famciclovir for the treatment of acute herpes zoster: effects of acute disease and postherpetic neuralgia: a randomized, double-blind, placebo-controlled trial. The Collaborative Famciclovir Herpes Zoster Study Group. Ann Intern Med 1995;123:89-96.
28. Jackson JL, Gibbons R, Meyer G, Inouye L. The effect of treating herpes zoster with oral acyclovir in preventing postherpetic neuralgia: a meta-analysis. Arch Intern Med 1997;157:909-912.
29. Beutner KR, Friedman DJ, Forszpaniak C, Andersen PL, Wood MJ. Valaciclovir compared with acyclovir for improved therapy for herpes zoster in immunocompetent adults. Antimicrob Agents Chemother 1995;39:1546-1553.
30. Tyring SK, Beutner KR, Bruce A, Tucker A, Anderson WC, Crooks RJ. Antiviral therapy for herpes zoster. Randomized, controlled trial of valacyclovir and famciclovir therapy in immunocompetent patients 50 years and older. Arch Fam Med 2000;9:863-869.
31. Johnson R, Patrick D, eds. Improving the Management of Varicella, Herpes Zoster and Zoster-associated Pain. International Herpes Management Forum, 2002. Available at http:// www.ihmf.org/library/ lib_mon.asp (last accessed 25 July 2003).
32. McKendrick MW, Care CC, Kudesia G, Oxley K, Eley AR. Varicella zoster virus reactivation as a cause of patients presenting with unilateral pain - a prospective study. In: The Third International Conference on the Varicella Zoster Virus. Palm Beach Gardens, Florida USA; 1997.
33. Wood MJ, Johnson RW, McKendrick MW, Taylor J, Mandal BK, Crooks J. A randomized trial of acyclovir for 7 days of 21 days with and without prednisolone for treatment of acute herpes zoster. N Engl J Med 1994;330:896-900.
34. Whitley RJ, Weiss H, Gnann JW, Tyring S, Mertz GJ, Pappas PG et al. Acyclovir with and without prednisone for the treatment of herpes zoster: a randomized, placebo-controlled trial, Ann Intern Med 1996;125:376-383.
35. Higa K, Hori K, Harasawi I, Hirata K, Dan K. High thoracic epidural block relieves acute herpetic pain involving the trigeminal and cervical regions: Comparison with effects of stellate ganglion block. Reg Anoesth Pain Med 1998;23:25-29.
36. Pasqualucci A, Pasqualucci V, Galla F, Paoletti F, Girardis M, Lugano M et al. Prevention of post-herpetic neuralgia: acyclovir and prednisolone versus epidural local anaesthetic and methylprednisolone. Acta Anaesthesiol Scand 2000;44:910-918.
37. Wu CL, Marsh A, Dworkin RH. The role of sympathetic nerve blocks in herpes zoster and postherpetic neuralgia. Pain 2000;87:121-129.
38. Bowsher DR. The effects of pre-emptive treatment of postherpetic neuralgia with amitriptyline: a randomized, double-blind, placebo-controlled trial. J Pain Symptom Manage 1997;13:327-331.
39. Farrar JT, Young JP, Jr, La Moreaux L, Werth JL, Poole RM. Clinical importance of changes in chronic pain intensity measured on an 11-point numerical rating scale. Pain 2001;94:149-158.
40. Kanazi GE, Johnson RW, Dworkin RH. Treatment of postherpetic neuralgia: an update. Drugs 2000;59:1113-1126.
41. Collins SL, Moore RA, McQuay HJ. Antidepressants and anticonvulsants for diabetic neuropathy and postherpetic neuralgia: a quantitative systematic review. J Pain Symptom Manage 2000;20:449-458.
42. Dallocchio C, Buffa C, Mazzarello P, Chiroli S. Gabapentin vs. amitriptyline in painful diabetic neuropathy: an open-label pilot study. J Pain Symptom Manage 2000;4:280-285.
43. Max MB, Schafer SC, Culnane M, Smoller B, Dubner R, Gracely RH. Amitriptyline, but not lorazepam, relieves postherpetic neuralgia. Neurology 1988;38:1427-1432.
44. Watson CP, Evans RJ, Reed K, Mershey H, Goldsmith L, Warsh J. Amitriptyline versus placebo in postherpetic neuralgia. Neurology 1982;32:671-673.
45. Watson CP, Vernich L, Chipman M, Reed K. Nortriptyline versus amitriptyline in postherpetic neuralgia: A randomized trial, Neurology 1998;51:1116-1171.
46. Kishore-Kumar R, Max MB, Schafer SC, Gaughan AM, Smaller B, Graceley RH et al. Desipramine relieves postherpetic neuralgia. Clin Pharmacol Ther 1990;47:305-312.
47. McCue RE, Using tricyclic antidepressants in the elderly. Clin Geriatr Med 1992;8:323-334.
48. Rowbotham M, Harden N, Stacey B, Bernstein P, Magnus-Miller L. Gabapentin for the treatment of postherpetic neuralgia. JAMA 1998:280:1837-1842.
49. Rice ASC, Maton S. Gabapentin in postherpetic neuralgia: a randomised, double-blind, placebo-controlled study. Pain 2001;94:215-224.
50. Dworkin RH, Corbin AE, Young JP, Sharma U, LaMoreaux L, Bockbrader H et al. Pregabalin for the treatment of postherpetic neuralgia: a randomized, placebo-controlled trial. Neurology 2003;60:1274-1283.
51. Devers A, Galer BS. Topical lidocaine patch relieves a variety of neuropathic pain conditions: an open-label study. Clin J Pain 2000;16:205-208.
52. Rowbotham MC, Davies PS, Verkempinck C, Galer BS. Lidocaine patch: double-blind controlled study of a new treatment method for post-herpetic neuralgia. Pain 1996;65:39-44.
53. Watson CP, Tyler KL, Bickers DR, Millikan LE, Smith S, Coleman E. A randomized vehicle-controlled trial of topical capsaicin in the treatment of postherpetic neuralgia. Clin Ther 1993;15:510-526.
54. Bowsher DR, Gill H. Aspirinin-chloroform lotion for topical pain relief in postherpetic neuralgia: a double-blind trial. J Pain Soc 1991;9:16-17.
55. De Benedittis G, Lorenzetti A. Topical aspirin/diethyl ether mixture versus indomethacin and diclofenac/diethyl ether mixtures for acute herpetic neuralgia and postherpetic neuralgia: a double-blind crossover placebo-controlled study. Pain 1996;65:45-51.
56. Dowd NP, Day F, Timon D, Cunningham AJ, Brown L. Iontophoretic vincristine in the treatment of postherpetic neuralgia: a double-blind, randomized, controlled trial. J Pain Symptom Manage 1999:17:175-180.
57. Layman PR, Argyras E, Glyn CJ. Iontophoresis of vincristine versus saline in post-herpetic neuralgia. A controlled trial. Pain 1986;25:165-170.
58. Watson CP, Babul N. Efficacy of oxycodone in neuropathic pain: a randomized trial in postherpetic neuralgia. Neurology 1998;50:1837-1841.
59. Gobel, H, Stadler T. Traitement des douleurs post-zosteriennes par le tramadol. Clin Drug Investig 1995;10:208-221.
60. Boureau F, Legallicier P, Kabir-Ahmadi M. Tramadol in post-herpetic neuralgia: a randomized, double-blind, placebo-controlled trial. Pain 2003;104:323-331.
61. Rowbotham MC, Twilling L, Davies PS, Reisner L, Taylor K, Mohr D. Oral opioid therapy for chronic peripheral and central neuropathic pain. N Engl J Med 2003;348:1223-1232.
62. Raja SN, Haythomthwaite JA, Pappagallo M, Clark MR, Travison TG, Sabeen S et al. Opioids versus antidepressants in postherpetic neuralgia: a randomized, placebo-controlled trial. Neurology 2002;59:1015-1021.
63. Eide PK, Jorum E, Stubhaug A, Bremnes J, Breivik H. Relief of post-herpetic neuralgia with the N-methyl-D-aspartic acid receptor antagonist ketamine: a double-blind, cross-over comparison with morphine and placebo. Pain 1994;58:347-354.
64. Nelson KA, Park KM, Robinovitz E, Tsigos C, Max MB. High-dose oral dextromethorphan versus placebo in painful diabetic neuropathy and postherpetic neuralgia. Neurology 1997;48:1212-1218.
65. Loeser J. Surgery for postherpetic neuralgia. In: Herpes Zoster and Postherpetic Neuralgia (Watson CPN, ed). Amsterdam: Elsevier 1993; pp221-237.
66. Kotani N, Kushikata T, Hashimoto H, Kimura F, Muraoka M, Yodono M et al. Intrathecal methylprednisolone for intractable postherpetic neuralgia. N Engl J Med 2000;23:1514-1519.
67. Nelson DA. Dangers from methylprednisolone acetate therapy by intraspinal injection. Arch Neurol 1988;45:804-806.
68. Nelson DA, Landau WM. N Engl J Med 2001;344:1019; author reply 1021-1022.
69. Argoff CE. A focused review on the use of botulinum toxins for neuropathic pain, Clin J Pain 2002;18(Suppl 6): S177-S181.
70. Johnson RW, Mandal BK. Guidelines for the management of shingles. Report of a working group of the British Society for the Study of Infection (BSSI), J Infect 1995;30:193-200.